CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

In-stent neoatherosclerosis: a final common pathway of late stent failure Meta-Analysis of Effectiveness and Safety of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Low-to-Intermediate Surgical Risk Cohort Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced Heart Failure With Preserved Ejection Fraction in the Young Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

Review Article2012 Jun 5;59(23):2051-7.

JOURNAL:J Am Coll Cardiol. Article Link

In-stent neoatherosclerosis: a final common pathway of late stent failure

Park SJ, Kang SJ, Virmani R et al. Keywords: PCI; stenting; in-stent neoatherosclerosis; late stent failure; intravascular imaging

FULL TEXT PDF